Di Cao

机构：Jiangxi University of Traditional Chinese Medicine, Cancer Research Center · ORCID：0000-0002-1205-1556

发表论文 52 篇 · 总被引 588 次 · h-index 14

代表论文

• Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B‐cell lymphoma (2021 · Hematological Oncology · 被引 36)
• Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11/GPX4/ACSL4 axis (2025 · Cellular Signalling · 被引 16)
• Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway (2022 · Evidence-based Complementary and Alternative Medicine · 被引 9)
• Prediction of wax deposition and optimization of pigging intervals in shale oil multiphase pipelines (2025 · Process Safety and Environmental Protection · 被引 8)
• Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab (2024 · BioDrugs · 被引 8)
• Bruceine D inhibits CAF-promoted angiogenesis of breast cancer via suppressing IL-6-mediated activation of the STAT3/Notch1/VEGFR2 axis (2025 · European Journal of Pharmacology · 被引 7)